XORTX Therapeutics Inc. (XRTX) — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2021)

-CA$1.7M

Total Assets (FY2021)

CA$22.0M

Total Equity (FY2021)

CA$16.7M

Cash Flows from Operating Activities (FY2021)

-CA$6.1M

Source: XORTX Therapeutics Inc. 20-F filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.